AVDL
Avadel Pharmaceuticals plc
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IE
$21.64
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 21.39x
- Price / sales
- 8.46x
- Price / cash flow
- 59.03x
Enterprise value
- Enterprise value
- $2.0B
- EV / sales
- 8.24x
- EV / EBITDA
- 202.09x
- EV / EBIT
- 452.60x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2025